Here, we report two unrelated individuals with MFS and MASS syndrome, respectively, which were associated with different intronic variants in FBN1. Characterization of the effects of these variants on mRNA allowed us to support their pathogenicity and, therefore, to use them for patient and family management. The gene discussed is FBN1; the disease is Marfan syndrome.